Innovation AveNEW Program
MINNEAPOLIS (WCCO) — Be sure to stop by the newly redesigned Innovation AveNEW in the SLAS2017 Exhibition to visit with these companies and see the technology which earned this important distinction.
Innovation AveNEW is a traditional highlight of the annual SLAS Conference and Exhibition. Through this program, SLAS provides start-up companies with tremendous exposure and prestige by granting complimentary exhibit space and in-kind support that enables the company’s participation at the SLAS Annual Conference & Exhibition. Innovation AveNEW participants are selected by a committee of SLAS volunteers that judges applicants based on a set of criteria that includes the impact of the technology, commercial viability, and potential impact on the field of laboratory automation and technology.
StemoniX is leading the development and manufacturing of human induced pluripotent stem cells for academic and industrial pharmaceutical research and discovery applications, such as biologically accurate, miniaturized organ-like microtissues. Its biotechnology provides scientists the ultimate “in vitro” testing environment with standardized, easy-to-use, cost-effective access to relevant human microtissue for toxicity and efficacy screening. Incorporated in Minnesota, the company is co-located in Minneapolis and San Diego, Calif. For more information visit www.stemonix.com.